Guarini Kathryn
SEC CIK 1992352 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals | Dir | 1,003 | — | $660.0K | 8 | 2023-09-08 | 2026-09-02 |
Most active insiders at REGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | POON CHRISTINE A | Dir | — | $4.25M |
| 2 | McCourt Marion | EVP Commercial | — | $2.00M |
| 3 | Zoghbi Huda Y | Dir | — | $1.92M |
| 4 | Pitofsky Jason | VP Ctrl | — | $1.87M |
| 5 | Bassler Bonnie L | Dir | — | $1.77M |
| 6 | Guarini Kathryn | Dir | — | $660.0K |
| 7 | RYAN ARTHUR F | Dir | — | $434.7K |
| 8 | MURPHY ANDREW J | EVP Research | — | — |
| 9 | Fenimore Christopher R. | EVP Fin CFO | — | — |
| 10 | Schenkein David P | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-03 16:47 | 2026-09-02 | REGN | Regeneron Pharmaceuticals | Guarini Kathryn | Dir | M - OptEx | $719.37 | +400 | 1,003 | +66% | +$287.7K |
| DT | 2026-09-03 16:47 | 2026-09-02 | REGN | Regeneron Pharmaceuticals | Guarini Kathryn | Dir | S - Sale+OE | $850.00 | -400 | 603 | -40% | -$340.0K |
| DT | 2026-08-12 16:16 | 2026-08-10 | REGN | Regeneron Pharmaceuticals | Guarini Kathryn | Dir | M - OptEx | $719.37 | +400 | 1,003 | +66% | +$287.7K |
| DT | 2026-08-12 16:16 | 2026-08-10 | REGN | Regeneron Pharmaceuticals | Guarini Kathryn | Dir | S - Sale+OE | $800.00 | -400 | 603 | -40% | -$320.0K |
| D | 2026-01-06 | 2026-01-02 | REGN | Regeneron Pharmaceuticals | Guarini Kathryn | Dir | A - Grant | $0.00 | +155 | 603 | +35% | $0 |
| D | 2025-01-06 | 2025-01-02 | REGN | Regeneron Pharmaceuticals | Guarini Kathryn | Dir | A - Grant | $0.00 | +166 | 448 | +59% | $0 |
| D | 2024-01-04 | 2024-01-02 | REGN | Regeneron Pharmaceuticals | Guarini Kathryn | Dir | A - Grant | $0.00 | +42 | 282 | +18% | $0 |
| D | 2023-09-12 | 2023-09-08 | REGN | Regeneron Pharmaceuticals | Guarini Kathryn | Dir | A - Grant | $0.00 | +240 | 240 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations